Esperion Therapeutics, Inc.

Historical 13F Holders

Symbol
ESPR
CUSIP
29664W105
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 191 113 M $164 M
2024 Q4 208 126 M $278 M
2024 Q3 202 131 M $217 M
2024 Q2 196 142 M $316 M
2024 Q1 173 131 M $350 M
2023 Q4 150 75.8 M $227 M
2023 Q3 137 77.3 M $75.9 M
2023 Q2 141 74.4 M $104 M
2023 Q1 187 81.0 M $129 M
2022 Q4 191 75.7 M $472 M
2022 Q3 165 63.4 M $426 M
2022 Q2 149 55.4 M $352 M
2022 Q1 146 52.0 M $241 M
2021 Q4 155 53.7 M $269 M
2021 Q3 156 24.8 M $299 M
2021 Q2 160 28.3 M $599 M
2021 Q1 175 28.7 M $805 M
2020 Q4 175 30.9 M $822 M
2020 Q3 187 31.6 M $1.18 B
2020 Q2 215 32.0 M $1.64 B
2020 Q1 192 29.8 M $931 M
2019 Q4 204 28.3 M $1.65 B
2019 Q3 176 27.0 M $991 M
2019 Q2 199 29.3 M $1.36 B
2019 Q1 189 27.6 M $1.11 B
2018 Q4 184 27.1 M $1.25 B
2018 Q3 188 28.6 M $1.27 B
2018 Q2 183 31.0 M $1.21 B
2018 Q1 215 26.7 M $1.93 B
2017 Q4 186 24.3 M $1.60 B
2017 Q3 174 24.3 M $1.22 B
2017 Q2 157 21.4 M $987 M
2017 Q1 144 18.4 M $650 M
2016 Q4 110 14.9 M $187 M
2016 Q3 115 14.5 M $200 M
2016 Q2 111 14.7 M $148 M
2016 Q1 121 15.9 M $268 M
2015 Q4 128 17.9 M $398 M
2015 Q3 134 16.6 M $392 M
2015 Q2 172 17.0 M $1.39 B
2015 Q1 154 14.9 M $1.38 B
2014 Q4 88 9.83 M $398 M
2014 Q3 50 5.56 M $136 M
2014 Q2 44 5.61 M $88.9 M
2014 Q1 41 3.43 M $51.9 M